Synagis Palivizumab
Discover our top-rated Synagis (Palivizumab) for powerful RSV prevention in high-risk infants and children. Synagis is an FDA-approved monoclonal antibody that provides advanced immune protection against respiratory syncytial virus, reducing risk of severe infection and hospitalization. Trusted by pediatricians and hospitals, Synagis supports optimal lung health and immunity during RSV season. Ensure superior respiratory defense for your child with our reliable Synagis solutions.
-
Sale 17%
Original price $ 2,999.95Current price $ 2,495.00Synagis palivizumab 50mg/0.5 mL Single-Dose Vial
SobiSynagis palivizumab 50mg/0.5 mL Single-Dose Vial is a highly effective medication used for the prevention of serious respiratory tract infections c...
View full details -
Sale 13%
Original price $ 5,600.95Current price $ 4,900.00Synagis palivizumab 100mg/1 mL Single-Dose Vial
SobiSynagis is the only FDA-approved monoclonal antibody to help protect high-risk infants against RSV. Synagis palivizumab 100mg/1 mL Single-Dose Vial...
View full details
Discover our top-rated Synagis (Palivizumab) for powerful RSV prevention in high-risk infants and children. Synagis is an FDA-approved monoclonal antibody that provides advanced immune protection against respiratory syncytial virus, reducing risk of severe infection and hospitalization. Trusted by pediatricians and hospitals, Synagis supports optimal lung health and immunity during RSV season. Ensure superior respiratory defense for your child with our reliable Synagis solutions.